Medivir AB (publ)

Medivir AB (publ)verified

MVRBF

Price:

$0.82

Market Cap:

$402.33M

Medivir AB (publ) researches, develops, and sells pharmaceuticals primarily for the treatment of oncology in Sweden and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name. It also develops Remetinostat for treating MF cutaneous T-cell lymphoma, as well as basal cell carcinoma. In addition, the company develops MIV-818 for the treatment of liver cancer; MIV-711 to treat osteoarthritis; and Birinapant and IGM-8444 for the treatment of solid tumors. It has a research collaboration with the Drug Discovery and Development Platform at SciLifeLab for the discovery of antivirals for SARS CoV-2; and a licensing agreement with the Tango Therapeutics...[Read more]

Industry

Biotechnology

IPO Date

2010-06-22

Stock Exchange

OTC

Ticker

MVRBF

The Current Ratio as of November 2025 (TTM) for Medivir AB (publ) (MVRBF) is 4.39

According to Medivir AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 4.39. This represents a change of 20.20% compared to the average of 3.65 of the last 4 quarters.

Medivir AB (publ) (MVRBF) Historical Current Ratio (quarterly & annually)

How has MVRBF Current Ratio performed in the past?

The mean historical Current Ratio of Medivir AB (publ) over the last ten years is 5.28. The current 4.39 Current Ratio has changed 8.21% with respect to the historical average. Over the past ten years (40 quarters), MVRBF's Current Ratio was at its highest in in the September 2014 quarter at 11.67. The Current Ratio was at its lowest in in the December 2020 quarter at 2.28.

Quarterly (TTM)
Annual

Average

5.28

Median

4.74

Minimum

2.28

Maximum

9.47

Medivir AB (publ) (MVRBF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Medivir AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 137.88%

Maximum Annual Current Ratio = 9.47

Minimum Annual Increase = -49.45%

Minimum Annual Current Ratio = 2.28

Quarterly (TTM)
Annual
YearCurrent RatioChange
20224.39-18.88%
20215.42137.88%
20202.28-18.10%
20192.78-13.50%
20183.21-32.90%
20174.79-49.45%
20169.4731.78%
20157.19-16.69%
20148.6384.10%
20134.6958.24%

Medivir AB (publ) (MVRBF) Average Current Ratio

How has MVRBF Current Ratio performed in the past?

The current Current Ratio of Medivir AB (publ) (MVRBF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

4.03

5-year avg

3.62

10-year avg

5.28

Medivir AB (publ) (MVRBF) Current Ratio vs. Peers

How is MVRBF’s Current Ratio compared to its peers?

Medivir AB (publ)’s Current Ratio is greater than Abliva AB (publ) (4.13), greater than Relief Therapeutics Holding AG (4.05), greater than Oncopeptides AB (publ) (3.42), greater than Biostage, Inc. (0.91), less than Small Pharma Inc. (5.77), greater than Mindset Pharma Inc. (1.18), greater than Alpha Cognition Inc. (1.50), less than Herantis Pharma Oyj (8.10), less than Karolinska Development AB (publ) (7.99), greater than IntelGenx Technologies Corp. (0.41),

Build a custom stock screener for Medivir AB (publ) (MVRBF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medivir AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Medivir AB (publ) (MVRBF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Medivir AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Medivir AB (publ)'s Current Ratio?

How is the Current Ratio calculated for Medivir AB (publ) (MVRBF)?

What is the highest Current Ratio for Medivir AB (publ) (MVRBF)?

What is the 3-year average Current Ratio for Medivir AB (publ) (MVRBF)?

What is the 5-year average Current Ratio for Medivir AB (publ) (MVRBF)?

How does the current Current Ratio for Medivir AB (publ) (MVRBF) compare to its historical average?